FibroGen rebrands as Kyntra Bio, trades under KYNB starting January 8 Jan 7, 2026 07:33AM
FibroGen's roxadustat gets orphan drug status for rare blood disorder Dec 15, 2025 07:02AM
FibroGen (FGEN) Misses Q3 EPS by 325c Nov 10, 2025 05:32PM
H.C. Wainwright Reiterates Buy Rating on FibroGen (FGEN) Sep 25, 2025 06:44AM
H.C. Wainwright Reiterates Buy Rating on FibroGen (FGEN) Sep 3, 2025 06:52AM


Aug 18, 2025 07:01AM FibroGen receives China approval for AstraZeneca unit sale
Aug 11, 2025 04:03PM FibroGen (FGEN) Misses Q2 EPS by $1.79
Aug 7, 2025 07:00AM FibroGen reaches FDA agreement on Phase 3 trial design for roxadustat
Jun 12, 2025 04:02PM FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split
Jun 9, 2025 04:02PM FibroGen (FGEN) Appoints Michael Kauffman to its Board
May 13, 2025 07:36AM FibroGen (FGEN) Tops Q1 EPS by 15c
Mar 28, 2025 07:00AM FibroGen (FGEN) Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246
Mar 17, 2025 04:13PM FibroGen (FGEN) Tops Q4 EPS by 35c
Feb 21, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on FibroGen (FGEN)
Feb 20, 2025 06:33AM FibroGen (FGEN) Sells FibroGen China to AstraZeneca (AZN) for $160M
Dec 17, 2024 07:57AM H.C. Wainwright Starts FibroGen (FGEN) at Buy
Dec 16, 2024 08:05AM FibroGen (FGEN) Appoints David DeLucia as CFO
Nov 12, 2024 04:22PM FibroGen (FGEN) Tops Q3 EPS by 14c, Misses on Revenue; Offers FY24 Revenue Guidance
Aug 6, 2024 04:30PM FibroGen (FGEN) Tops Q2 EPS by 16c ; Offers Guidance
Jul 31, 2024 10:58AM Increasing unusual put option volume: FGEN LSCC GPN SHW MAR TELL ALAB
Jul 31, 2024 09:36AM FibroGen (FGEN) PT Lowered to $0.60 at Goldman Sachs
Jul 23, 2024 05:19AM Increasing unusual put volume: FGEN TELL NDAQ PTEN BK CRWD COPX
Jun 28, 2024 05:11PM FibroGen (FGEN) Files $300M Mixed Shelf